Observational Study of Type 1 and Type 2 Diabetes Patients Having Switched From Human Premixes to NovoMix®30
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this observational study is to evaluate the
blood glucose control (HbA1c) using NovoMix® 30 for treatment of type 1 and type 2 diabetes
under normal clinical practice conditions in Romania.